Fig. 1
Comparisons of (a) CSF Aβ1–42, (b) CSF Aβ1–40, (c) CSF Aβ1–42/Aβ1–40, (d) CSF t-tau, (e) CSF p-tau, (f) CSF p-tau/t-tau ratio, (g) CSF NfL, (h) CSF pNfH, (i) CSF sTREM2, (j) CSF GFAP, and (k) serum NfL between the HSV/VZV and control groups. The CSF (HSV/VZV group: n = 17; control: n = 18) and serum (HSV/VZV group: n = 9; control: n = 6) levels of those biomarkers in each individual are shown as black dots. Bars indicate median values. n.s., not significant